Favourable safety and tolerability profile of coadministered amlodipine and atorvastatin in patients with concomitant hypertension and dyslipidemia: Results from the respond trial

被引：0
|
作者：
Preston, R. A.
Jukema, J. W.
Harvey, P.
Sun, F.
Tarasenko, L.
机构：
[1] Univ Miami, Miller Sch Med, Div Clin Pharmacol & Pharmacokinet, Miami, FL 33152 USA
[2] Leiden Univ, Med Ctr, Dept Cardiol C5 P, Leiden, Netherlands
[3] Crouch Oak Family Practice, Addlestone, Surrey, England
[4] Pfizer Inc, New York, NY USA
来源：
JOURNAL OF HYPERTENSION | 2006年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：S82 / S83
页数：2
相关论文
共 50 条
  • [1] Safety and tolerability of coadministered amlodipine and atorvastatin in patients with concomitant hypertension and dyslipidemia in the Respond study
    Jukema, J. W.
    Preston, R. A.
    Sun, F.
    Tarasenko, L.
    EUROPEAN HEART JOURNAL, 2005, 26 : 581 - 582
  • [2] Safety and tolerability of coadministered amlodipine and atorvastatin in patients with concomitant hypertension and dyslipidemia in the respond study
    Preston, RA
    Sun, F
    Tarasenko, L
    AMERICAN JOURNAL OF HYPERTENSION, 2005, 18 (05) : 92A - 93A
  • [3] A randomized, placebo-controlled trial to evaluate the efficacy, safety, and pharmacodynamic interaction of coadministered Amlodipine and atorvastatin in 1660 patients with concomitant hypertension and dyslipidemia: The respond trial
    Preston, Richard A.
    Harvey, Peter
    Herfert, Ottmar
    Dykstra, Gary
    Jukema, J. Wouter
    Sun, Franklin
    Gillen, David
    JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 47 (12): : 1555 - 1569
  • [4] Coadministered amlodipine and atorvastatin reduces framingham cardiovascular risk: Results from the respond trial
    Preston, R. A.
    Jukema, J. W.
    Harvey, P.
    Herfert, O.
    Dykstra, G.
    Sun, F.
    Gillen, D.
    JOURNAL OF HYPERTENSION, 2006, 24 : S23 - S23
  • [5] The efficacy and safety of fixed-dose combinations of amlodipine and atorvastatin in the treatment of patients with concomitant hypertension and dyslipidemia
    Preston, RA
    Harvey, P
    Herfert, O
    Dykstra, G
    AMERICAN JOURNAL OF HYPERTENSION, 2004, 17 (05) : 185A - 185A
  • [6] Efficacy and safety of atorvastatin plus amlodipine versus either agent alone in patients with concomitant dyslipidemia and hypertension: The AVALON study
    Flack, J
    Houston, M
    Neutel, J
    Ferrera, D
    Gillen, D
    Gibson, E
    JOURNAL OF HYPERTENSION, 2004, 22 : S12 - S12
  • [7] Fixed-dose combination of amlodipine and atorvastatin improves clinical outcomes in patients with concomitant hypertension and dyslipidemia
    Lin, Chia-Pin
    Tung, Ying-Chang
    Hsiao, Fu-Chih
    Yang, Chia-Hung
    Kao, Yi-Wei
    Lin, Yu-Sheng
    Chu, You-Chia
    Chu, Pao-Hsien
    JOURNAL OF CLINICAL HYPERTENSION, 2020, 22 (10): : 1846 - 1853
  • [8] EFFICACY AND SAFETY OF A SINGLE-PILL COMBINATION OF ATORVASTATIN/AMLODIPINE IN PATIENTS WITH ARTERIAL HYPERTENSION AND DYSLIPIDEMIA
    Naydenov, Stefan Naydenov
    Runev, Nikolay Margaritov
    Manov, Emil Ivanov
    Torbova-Gigova, Svetla Georgieva
    ACTA CLINICA CROATICA, 2018, 57 (03) : 464 - 472
  • [9] Efficacy, Safety, Tolerability, and Pharmacokinetic Profile of Evacetrapib Administered as Monotherapy or in Combination With Atorvastatin in Japanese Patients With Dyslipidemia
    Teramoto, Tamio
    Takeuchi, Masakazu
    Morisaki, Yoji
    Ruotolo, Giacomo
    Krueger, Kathryn A.
    AMERICAN JOURNAL OF CARDIOLOGY, 2014, 113 (12): : 2021 - 2029
  • [10] Utility of low doses of single-pill amlodipine besylate/atorvastatin calcium in the control of concomitant hypertension and dyslipidemia: Results of a pooled analysis of 2572 patients
    Feldman, R. D.
    Da Silva, P. Marques
    Blank, R. C.
    Erdine, S.
    Shi, H.
    Moller, R. A.
    Schou, I. M.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2008, 23 : 436 - 436
12345